RxDoctor Payments Data

Darrell Hutchison, MD

Family Medicine · Corning, ARNPI 1962441436

Payments from drug & device makers

$661in general payments, 2019–2025

Across 45 payments — averaging $14.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$253
  • Pfizer$79
  • Novo Nordisk$69
  • Sanofi Pasteur Inc.$46
  • AstraZeneca$43
  • Abbott$37
  • plus $133 from 8 others

What the payments were for

  • Food & beverage$661100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$661 in reported general payments places this provider in the 50th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$2,509
Medicare patients
72
Services billed
246

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin111$82,917
Tresiba Flextouch U-200Insulin Degludec49$62,115
OzempicSemaglutide69$58,470
EliquisApixaban64$48,917
Trelegy ElliptaFluticasone/Umeclidin/Vilanter67$40,998
TrulicityDulaglutide16$29,943
Tresiba Flextouch U-100Insulin Degludec31$22,038
FarxigaDapagliflozin Propanediol20$11,079
JanuviaSitagliptin Phosphate11$4,932
BrilintaTicagrelor11$4,445
Esomeprazole Magnesium97$4,206
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$3,579
Gabapentin221$3,055
Fluticasone Propionate HfaFluticasone Propionate11$2,803
Potassium Chloride234$2,292

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$69$58,47069 claims
PfizerEliquis$79$48,91764 claims
GSKTrelegy Ellipta$253$40,99867 claims
Lilly USA, LLCTrulicity$16$29,94316 claims
AstraZenecaFarxiga, Brilinta$43$15,52431 claims
MerckJanuvia$12$4,93211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Corning

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →